(19)
(11) EP 4 739 304 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 23749250.9

(22) Date of filing: 12.07.2023
(51) International Patent Classification (IPC): 
A61K 31/343(2006.01)
A61P 9/06(2006.01)
A61P 9/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/343; A61P 9/06; A61P 9/00
(86) International application number:
PCT/US2023/027521
(87) International publication number:
WO 2025/010071 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 05.07.2023 US 202363525093 P

(71) Applicant: Xyra, LLC
Santa Rosa, California 95403 (US)

(72) Inventors:
  • DRUZGALA, Pascal
    Santa Rosa, California 95403 (US)
  • MILNER, Peter Gerard
    Santa Rosa, California 95403 (US)

(74) Representative: Fuchs Patentanwälte Partnerschaft mbB 
Tower 185 Friedrich-Ebert-Anlage 35-37
60327 Frankfurt am Main
60327 Frankfurt am Main (DE)

   


(54) METHODS FOR TREATING ATRIAL FIBRILLATIONS WITH BUDIODARONE